| Primary |
| Drug Use For Unknown Indication |
33.3% |
| Pain |
33.3% |
| Phantom Pain |
22.2% |
| Cluster Headache |
11.1% |
|
| Drug Level Increased |
22.2% |
| Hallucination |
22.2% |
| Incorrect Dose Administered |
11.1% |
| Multiple Drug Overdose |
11.1% |
| Polysubstance Abuse |
11.1% |
| Rhabdomyolysis |
11.1% |
| Urinary Retention |
11.1% |
|
| Secondary |
| Product Used For Unknown Indication |
51.0% |
| Ill-defined Disorder |
6.9% |
| Drug Abuse |
5.9% |
| Drug Abuser |
5.9% |
| Drug Use For Unknown Indication |
3.9% |
| Intentional Overdose |
3.9% |
| Migraine |
3.9% |
| Pain |
2.9% |
| Phobia |
2.9% |
| Pain Management |
2.0% |
| Procedural Pain |
2.0% |
| Anxiety |
1.0% |
| Back Pain |
1.0% |
| Drug Dependence |
1.0% |
| Endometriosis |
1.0% |
| Fibromyalgia |
1.0% |
| Gastric Disorder |
1.0% |
| Joint Swelling |
1.0% |
| Laboratory Test |
1.0% |
| Neuropathy |
1.0% |
|
| Toxicity To Various Agents |
16.2% |
| Respiratory Arrest |
10.8% |
| Overdose |
8.1% |
| Therapeutic Agent Toxicity |
8.1% |
| Completed Suicide |
5.4% |
| Gamma-glutamyltransferase Increased |
5.4% |
| Respiratory Paralysis |
5.4% |
| Unresponsive To Stimuli |
5.4% |
| Weight Decreased |
5.4% |
| Alanine Aminotransferase Increased |
2.7% |
| Constipation |
2.7% |
| Drug Abuse |
2.7% |
| Drug Withdrawal Syndrome |
2.7% |
| Duodenal Ulcer |
2.7% |
| Intentional Drug Misuse |
2.7% |
| Intentional Overdose |
2.7% |
| Listless |
2.7% |
| Loss Of Employment |
2.7% |
| Metabolic Disorder |
2.7% |
| Muscle Rigidity |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.2% |
| Ill-defined Disorder |
10.0% |
| Drug Use For Unknown Indication |
6.7% |
| Back Pain |
5.6% |
| Non-small Cell Lung Cancer |
5.6% |
| Epilepsy |
4.4% |
| Infection |
4.4% |
| Metastatic Renal Cell Carcinoma |
4.4% |
| Neuralgia |
4.4% |
| Prophylaxis Of Nausea And Vomiting |
4.4% |
| Adenocarcinoma Of Colon |
3.3% |
| Arthritis |
3.3% |
| Asthma |
3.3% |
| Depression |
3.3% |
| Diabetic Neuropathy |
3.3% |
| Cellulitis |
2.2% |
| Chemotherapy |
2.2% |
| Chronic Lymphocytic Leukaemia |
2.2% |
| Grand Mal Convulsion |
2.2% |
| Immunosuppression |
2.2% |
|
| Vomiting |
11.1% |
| Muscular Weakness |
6.7% |
| Product Substitution Issue |
6.7% |
| Toxicity To Various Agents |
6.7% |
| Wheezing |
6.7% |
| Myocardial Infarction |
4.4% |
| Neutropenic Sepsis |
4.4% |
| Pain In Extremity |
4.4% |
| Pneumonia |
4.4% |
| Renal Failure Acute |
4.4% |
| Respiratory Failure |
4.4% |
| Skin Lesion |
4.4% |
| Thrombocytopenia |
4.4% |
| Treatment Noncompliance |
4.4% |
| Tremor |
4.4% |
| Visual Impairment |
4.4% |
| White Blood Cell Count Decreased |
4.4% |
| Withdrawal Syndrome |
4.4% |
| Abdominal Pain Upper |
2.2% |
| Angina Pectoris |
2.2% |
|
